Rozenn Esvan

592 total citations
16 papers, 110 citations indexed

About

Rozenn Esvan is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Rozenn Esvan has authored 16 papers receiving a total of 110 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Rozenn Esvan's work include Liver Disease Diagnosis and Treatment (5 papers), Hepatitis C virus research (5 papers) and Liver Disease and Transplantation (4 papers). Rozenn Esvan is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Hepatitis C virus research (5 papers) and Liver Disease and Transplantation (4 papers). Rozenn Esvan collaborates with scholars based in Italy, United Kingdom and Vietnam. Rozenn Esvan's co-authors include Elisa Biliotti, Gloria Taliani, Cristiana Franchi, Martina Spaziante, Tommaso Stroffolini, Evangelista Sagnelli, Giovanni Battista Gaeta, Piero Luigi Almasio, Lorenzo Volpicelli and Mario Venditti and has published in prestigious journals such as Journal of Hepatology, AIDS and Biomedicine & Pharmacotherapy.

In The Last Decade

Rozenn Esvan

14 papers receiving 109 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rozenn Esvan Italy 6 58 46 44 14 9 16 110
M. A. von Wichmann Spain 6 55 0.9× 27 0.6× 71 1.6× 10 0.7× 8 0.9× 10 103
Aarthi Chary United States 8 68 1.2× 53 1.2× 80 1.8× 16 1.1× 11 1.2× 15 163
Nicoletta Di Lauria Italy 5 16 0.3× 38 0.8× 61 1.4× 20 1.4× 7 0.8× 10 132
Tahar Hadou France 6 80 1.4× 25 0.5× 64 1.5× 27 1.9× 14 1.6× 9 135
Raul Davaro United States 6 22 0.4× 39 0.8× 66 1.5× 4 0.3× 8 0.9× 8 93
F Brun Spain 6 73 1.3× 37 0.8× 79 1.8× 21 1.5× 8 0.9× 10 147
Viola Guardigni Italy 6 27 0.5× 33 0.7× 52 1.2× 15 1.1× 8 0.9× 18 119
Carolyn Z. Grimes United States 9 110 1.9× 134 2.9× 214 4.9× 24 1.7× 18 2.0× 12 276
Cato Jacobs Belgium 7 24 0.4× 106 2.3× 72 1.6× 5 0.4× 13 1.4× 8 146
Nazan Tuna Türkiye 6 24 0.4× 21 0.5× 52 1.2× 3 0.2× 8 0.9× 16 105

Countries citing papers authored by Rozenn Esvan

Since Specialization
Citations

This map shows the geographic impact of Rozenn Esvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rozenn Esvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rozenn Esvan more than expected).

Fields of papers citing papers by Rozenn Esvan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rozenn Esvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rozenn Esvan. The network helps show where Rozenn Esvan may publish in the future.

Co-authorship network of co-authors of Rozenn Esvan

This figure shows the co-authorship network connecting the top 25 collaborators of Rozenn Esvan. A scholar is included among the top collaborators of Rozenn Esvan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rozenn Esvan. Rozenn Esvan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vergori, Alessandra, Giulia Matusali, Alessandro Cozzi Lepri, et al.. (2025). Supporting equitable booster strategies: one-year real-world immunogenicity data in people with HIV (PWH) receiving different variant-adapted COVID-19 vaccines. International Journal of Infectious Diseases. 163. 108189–108189.
2.
Moschese, Davide, Marc Maresca, Rozenn Esvan, et al.. (2025). Mental health, stigma and risk perception among early adopters of HIV PrEP with LA Cabotegravir in Italy: a multicenter cross-sectional and implementation study. International Journal of Infectious Diseases. 163. 108273–108273.
3.
Cicalini, Stefania, Simone Lanini, Roberta Gagliardini, et al.. (2024). Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort Study. Pharmaceuticals. 17(12). 1706–1706. 1 indexed citations
4.
Vergori, Alessandra, Patrizia Lorenzini, Ilaria Mastrorosa, et al.. (2024). Impact of switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate to bictegravir/emtricitabine/tenofovir alafenamide on psychiatric symptoms and neurocognition. AIDS. 39(3). 270–275. 3 indexed citations
5.
Rozera, Gabriella, Roberta Gagliardini, Rozenn Esvan, et al.. (2024). Human and Viral microRNA Expression in Acute and Chronic HIV Infections. Viruses. 16(4). 496–496. 2 indexed citations
6.
Abbate, Isabella, Gabriella Rozera, Eleonora Cimini, et al.. (2023). Kinetics of TTV Loads in Peripheral Blood Mononuclear Cells of Early Treated Acute HIV Infections. Viruses. 15(9). 1931–1931. 4 indexed citations
7.
Moretti, Sonia, Caterina Fimiani, Lucia Fontanelli Šuleková, et al.. (2021). Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy. Pathogens. 10(11). 1488–1488. 10 indexed citations
8.
Biliotti, Elisa, Ottavia Giampaoli, Fabio Sciubba, et al.. (2021). Urinary metabolomics of HCV patients with severe liver fibrosis before and during the sustained virologic response achieved by direct acting antiviral treatment. Biomedicine & Pharmacotherapy. 143. 112217–112217. 5 indexed citations
9.
Biliotti, Elisa, Francesca Tinti, Rozenn Esvan, et al.. (2020). HCV cirrhotic patients treated with direct‐acting antivirals: Detection of tubular dysfunction and resolution after viral clearance. Liver International. 41(1). 158–167. 3 indexed citations
10.
Biliotti, Elisa, Rozenn Esvan, Lorenzo Volpicelli, et al.. (2019). Vitamin D deficiency and health‐related quality of life in chronic hepatitis C. Journal of Viral Hepatitis. 26(6). 774–777. 1 indexed citations
11.
Spaziante, Martina, Cristiana Franchi, Gloria Taliani, et al.. (2019). Serum Bactericidal Activity Levels Monitor to Guide Intravenous Dalbavancin Chronic Suppressive Therapy of Inoperable Staphylococcal Prosthetic Valve Endocarditis: A Case Report. Open Forum Infectious Diseases. 6(11). ofz427–ofz427. 26 indexed citations
12.
Biliotti, Elisa, Ottavia Giampaoli, Alberta Tomassini, et al.. (2019). Metabolic Impact of HCV Clearance Examined by Urine Metabonomics in Patients with Severe Liver Fibrosis. SSRN Electronic Journal. 1 indexed citations
13.
Biliotti, Elisa, Cristiana Franchi, Martina Spaziante, et al.. (2018). Autochthonous acute hepatitis E: treatment with sofosbuvir and ribavirin. Infection. 46(5). 725–727. 20 indexed citations
14.
Biliotti, Elisa, Alberta Tomassini, Giorgio Capuani, et al.. (2017). Urinary metabotypes in patients with chronic hepatitis C virus infection as revealed by nuclear magnetic resonance-based metabolomics. Journal of Hepatology. 66(1). S236–S237. 1 indexed citations
15.
Stroffolini, Tommaso, Rozenn Esvan, Elisa Biliotti, et al.. (2015). Gender differences in chronic HBsAg carriers in Italy: Evidence for the independent role of male sex in severity of liver disease. Journal of Medical Virology. 87(11). 1899–1903. 22 indexed citations
16.
Stroffolini, Tommaso, Maria Rapicetta, Paola Chionne, et al.. (2015). Evidence for the presence of autochthonous (locally acquired) cases of acute hepatitis E virus infections in Italy since the 80s. European Journal of Internal Medicine. 26(5). 348–350. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. A. von Wichmann Breakdown of academic impact, for papers by Aarthi Chary Breakdown of academic impact, for papers by Nicoletta Di Lauria Breakdown of academic impact, for papers by Tahar Hadou Breakdown of academic impact, for papers by Raul Davaro Breakdown of academic impact, for papers by F Brun Breakdown of academic impact, for papers by Viola Guardigni Breakdown of academic impact, for papers by Carolyn Z. Grimes Breakdown of academic impact, for papers by Cato Jacobs Breakdown of academic impact, for papers by Nazan Tuna
Rankless by CCL
2026